Chatbots answered all mild distress cases well but just 58.3% of moderate ones in simulations
Researchers tested ChatGPT, Gemini, and Doubao with 20 simulated-patient scenarios covering type 2 diabetes and chronic spontaneous urticaria. Each scenario was submitted twice to each system, producing 120 responses that blinded raters scored for appropriateness, contextualization, referral, and safety.
Frontiers in Psychiatry
ace